Vidyya Medical News Service
*
Volume 6 Issue 342 Published - 14:00 UTC 08:00 EST 7-Dec-2004 Next Update - 14:00 UTC 08:00 EST 8-Dec-2004
little clear gif used for spacer
.
*

Got heart disease? The answer may be in your fingertips
A noninvasive fingertip test can identify patients with the earliest stages of heart disease and may prove cost-effective as a screening test, according to the findings of a Mayo Clinic study published this week in the Journal of American College of Cardiology.  more

*
Penn epidemiological study shows difference in cardiovascular effects between Vioxx and Celebrex
In the first epidemiological study designed and executed specifically to determine the heart-attack risk associated with COX-2 inhibitors rofecoxib (Vioxx) and celecoxib (Celebrex), researchers at the University of Pennsylvania School of Medicine found a greater risk of heart attack associated with Vioxx than Celebrex, although neither of the two drugs showed a statistically significant elevated risk of heart attack relative to people who did not use the drugs.  more

*
Stanford study links obesity to hormonal changes from lack of sleep
The less you sleep, the more you may gain. So say Stanford University School of Medicine researchers, who found in a recent study that sleep loss leads to higher levels of a hormone that triggers appetite, lower levels of a hormone that tells your body it's full and an increased body mass index. more

 


*
Month of birth linked to risk of MS
In the northern hemisphere, being born in May is linked to an increased risk of developing multiple sclerosis later in life, while being born in November carries the lowest risk.  more

*
Pharmaceutical marketing tactics hold little sway with prescribing physicians
Pharmaceutical drug companies spend upward of $25 billion per year on promoting new drugs and distributing free samples to doctors, but new research shows such marketing devices have little impact on physicians and their prescribing behavior. more

*
New marrow transplant method developed at Stanford may eliminate fatal side effects
Bone marrow transplantation can cure lymphomas and leukemia, but in about half of the cases transplanted immune cells wind up attacking the patient's body, as well as the cancer. more

*
Peptide vaccine can produce complete remission in myeloid leukemia patients
Researchers from The University of Texas M. D. Anderson Cancer Center are reporting the first study to show that vaccination with a peptide that is abnormally expressed on myeloid leukemia cells can produce a complete molecular remission in some patients. more

 
little clear gif used for a space